Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Phys Ther Sport ; 58: 41-45, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-36116172

RESUMEN

OBJECTIVES: To determine whether collegiate dancers with chronic ankle instability (CAI) demonstrated impaired postural control during instrumented measures of single-leg static balance compared to dancers without CAI. DESIGN: Cross sectional design. SETTING: University dance studios. PARTICIPANTS: We included N = 39 dance majors from a large, public university. We stratified participants into CAI (n = 20, age = 20 ± 1.8, IdFAI = 17.3 ± 5.7, number of sprains = 1.9 ± 1.1) and Control groups (n = 19, age = 20 ± 1.2, IdFAI = 2.5 ± 3.0). MAIN OUTCOME MEASURES: Participants performed 3 x 10-s single-leg, static balance trials on a pressure mat in two different conditions, foot-flat eyes closed and demi-pointe eyes open. We measured six different time-to-boundary (TTB) measurements during each balance trial and calculated the average of the 3 trials for each condition. Participants also completed the Foot and Ankle Ability Measure (FAAM) sport and activities of daily living (ADL) questionnaires. RESULTS: The CAI group reported greater IdFAI and lower FAAM-ADL and FAAM-Sport scores compared to the control group. We observed no significant differences in TTB measurements between the CAI and control groups during either balance conditions. CONCLUSIONS: Instrumented measures of static postural control were not impaired in college dancers with CAI compared dancers without CAI.


Asunto(s)
Articulación del Tobillo , Inestabilidad de la Articulación , Humanos , Adolescente , Adulto Joven , Adulto , Tobillo , Universidades , Actividades Cotidianas , Estudios Transversales , Enfermedad Crónica , Equilibrio Postural
2.
Dis Model Mech ; 10(12): 1465-1480, 2017 12 19.
Artículo en Inglés | MEDLINE | ID: mdl-29061563

RESUMEN

Polyglutamine expansion diseases are a group of hereditary neurodegenerative disorders that develop when a CAG repeat in the causative genes is unstably expanded above a certain threshold. The expansion of trinucleotide CAG repeats causes hereditary adult-onset neurodegenerative disorders, such as Huntington's disease, dentatorubral-pallidoluysian atrophy, spinobulbar muscular atrophy and multiple forms of spinocerebellar ataxia (SCA). The most common dominantly inherited SCA is the type 3 (SCA3), also known as Machado-Joseph disease (MJD), which is an autosomal dominant, progressive neurological disorder. The gene causatively associated with MJD is ATXN3 Recent studies have shown that this gene modulates endoplasmic reticulum (ER) stress. We generated transgenic Caenorhabditiselegans strains expressing human ATXN3 genes in motoneurons, and animals expressing mutant ATXN3-CAG89 alleles showed decreased lifespan, impaired movement, and rates of neurodegeneration greater than wild-type ATXN3-CAG10 controls. We tested three neuroprotective compounds (Methylene Blue, guanabenz and salubrinal) believed to modulate ER stress and observed that these molecules rescued ATXN3-CAG89 phenotypes. Furthermore, these compounds required specific branches of the ER unfolded protein response (UPRER), reduced global ER and oxidative stress, and polyglutamine aggregation. We introduce new C. elegans models for MJD based on the expression of full-length ATXN3 in a limited number of neurons. Using these models, we discovered that chemical modulation of the UPRER reduced neurodegeneration and warrants investigation in mammalian models of MJD.


Asunto(s)
Ataxina-3/metabolismo , Proteínas de Caenorhabditis elegans/metabolismo , Caenorhabditis elegans/metabolismo , Estrés del Retículo Endoplásmico , Neuronas Motoras/patología , Animales , Animales Modificados Genéticamente , Caenorhabditis elegans/efectos de los fármacos , Cinamatos/farmacología , Cinamatos/uso terapéutico , Estrés del Retículo Endoplásmico/efectos de los fármacos , Guanabenzo/farmacología , Guanabenzo/uso terapéutico , Humanos , Longevidad , Azul de Metileno/farmacología , Azul de Metileno/uso terapéutico , Mutación/genética , Degeneración Nerviosa/complicaciones , Degeneración Nerviosa/patología , Estrés Oxidativo/efectos de los fármacos , Parálisis/complicaciones , Parálisis/tratamiento farmacológico , Fenotipo , Agregado de Proteínas/efectos de los fármacos , Proteínas Represoras/metabolismo , Bibliotecas de Moléculas Pequeñas/farmacología , Bibliotecas de Moléculas Pequeñas/uso terapéutico , Tiourea/análogos & derivados , Tiourea/farmacología , Tiourea/uso terapéutico , Transgenes , Respuesta de Proteína Desplegada/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA